HIGR 10-K & 10-Q changes, risk factors and insider trading
Hi-Great Group Holding Co · OTC · Hotels & Motels · CIK 1807616 · All filings on SEC.gov
At a glance
What changed in the latest 10-K
Risk Factors
We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and, as such, are not required to provide the information under this Item.
No wording changes found in this section.
Full comparison: every changed paragraph (0)
Management's Discussion & Analysis (MD&A)
Largest changes
“For the year ended December 31, 2025 we incurred $6,454 of amortization expense compared to $20,673 for the year ended December 31, 2024. The decrease in amortization is mainly due to the lease expiration, and currently the operations of Nutritional Health Supplements operate with minimal to no rental costs.”see in full comparison
Wesee in full comparisongenerated$16,127used $89,608 from operating activities for the year ended December 31, 2025, compared to the used cash of $36,800 for the year ended December 31,2024, compared to the used cash of $40,435 for the year ended December 31, 2023.2024.
see in full comparisonAs reflected in the accompanying financial statements, the Company has just recently begun to generate revenue.We have an accumulated deficit of$892,794$980,002 and had a net loss of$48,616$87,208 for the year ended December 31,2024.2025.
“We received $20,673 from investing activities for the year ended December 31, 2024, compared to $29,435 received for the year ended December 31, 2023.”see in full comparison
“For the year ended December 31, 2024 we incurred $20,673 of depreciation expense compared to $27,565 for the year ended December 31, 2023.”see in full comparison
For the year ended December 31,see in full comparison20242025 we incurred$50,050$37,421 of professional fee expenses compared to$87,997$50,050 for the year ended December 31,2023.2024. The decreaseofin professional fees in the current period is attributed to a decrease inaudit, legalservices and accounting expenses.
Full comparison: every changed paragraph (9)
For
the year ended December 31, 20242025 we incurred $50,050 $37,421
of professional fee expenses compared to $87,997$50,050 for the year ended December 31,
2023. 2024. The decrease ofin professional fees in the current
period is attributed to a decrease in audit, legalservices and accounting expenses.
Depreciation
Amortization Expense
For the year ended December 31, 2025 we incurred $6,454 of amortization expense compared to $20,673 for the year ended December 31, 2024. The decrease in amortization is mainly due to the lease expiration, and currently the operations of Nutritional Health Supplements operate with minimal to no rental costs.
For
the year ended December 31, 2024 we incurred $20,673 of depreciation expense compared to $27,565 for the year ended December 31, 2023.
For
the year ended December 31, 20242025 we incurred $12,754 $18,625
of G&A expense compared to $54,838$12,754 for the year ended December 31, 2023.2024. The
decrease increase in the current year is attributed to lower higher
operational expenses.
As
reflected in the accompanying financial statements, the Company has just recently begun to generate revenue. We have an accumulated deficit
of $892,794$980,002 and had
a net loss of $48,616$87,208 for the year ended December 31, 2024.2025.
We
generated $16,127used $89,608 from operating activities for the
year ended December 31, 2025, compared to the used cash of $36,800 for the year ended December 31, 2024, compared to the used cash of $40,435 for the year ended
December 31, 2023.2024.
We
received $20,673 from investing activities for the year ended December 31, 2024, compared to $29,435 received for the year ended December
31, 2023.
We
used $34,660generated $87,990 from financing activities for
the year ended December 31, 2024,2025, compared to $19,577$34,660 cash used for the year ended December
31, 2023.2024.
What changed in the latest 10-Q
Risk Factors
We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and, as such, are not required to provide the information under this Item; however, due to the current circumstance we have chosen to include the following risk factor.
On January 30, 2020, the World Health Organization declared the coronavirus outbreak a “Public Health Emergency of International Concern” and on March 10, 2020, declared it to be a pandemic. The coronavirus and actions taken to mitigate it have had and are expected to continue to have an adverse impact on the economies and financial markets of many countries, including the geographical area in which the Company operates. While it is unknown how long these conditions will last and what the complete financial effect will be on the company, to date, the Company has not experienced a material impact.
No wording changes found in this section.
Full comparison: every changed paragraph (0)
Management's Discussion & Analysis (MD&A)
New heading “Results of Operation for the Six Months Ended June 30, 2026 and 2025”
New heading “Sales and Cost of Sales”
New heading “Professional fees”
New heading “General and administrative”
New heading “Other income (expense)”
Largest changes
“Results of Operation for the Six Months Ended June 30, 2026 and 2025”see in full comparison
“For the six months ended June 30, 2026, we had $20,210 of sales compared to $19,018 for the six months ended June 30, 2025. Our cost of sales for the six months ended June 30, 2026, was $11,113 compared to $12,105 for the six months ended June 30, 2025. The Company started to generate revenue in the beginning of 2020.”see in full comparison
Full comparison: every changed paragraph (19)
Results of Operation for the Threethree
Months Months
Ended MarchJune 31,30, 2026 and 2025
For the three months ended MarchJune 31,30, 2026, we had
had $13,255$6,955 of sales compared to $8,883$10,135 for the three months ended MarchJune 31,30, 2025. Our cost of sales for the three months ended March
31,June 30, 2026,
was $7,274$3,839 compared to $7,501$4,604 for the three months ended MarchJune 31,30, 2025. The Company started to generate revenue in the beginning
of 2020.
For the three months ended MarchJune 31,30, 2026, we incurred
incurred $8,802 of professional fee expenses compared to $9,950$13,215 for the three months ended MarchJune 31,30, 2025. The decrease in professional
fees in
the current period is attributed to ana increasedecrease ofin accounting service and audit expenses.
For the three months ended MarchJune 31,30, 2026, we incurred
incurred $4,385$6,027 of general and administrative expense (“G&A”) compared to $3,916$7,554 for the three months ended MarchJune 31,
30, 2025. The increase
decrease in the current year is attributed to an decrease in badfees debtand expenses,contractor offset by other G&A expenses in this quarter.expenses.
For the three months ended MarchJune 31,30, 2026, we had
had an interest expense of $624, compared to misc. income of $438$- for the three months ended MarchJune 31,30, 2025.
For the three months ended MarchJune 31,30, 2026, the
Company had a net loss of $7,830$12,337 as compared to a net loss of $18,938$17,044 for the three months ended MarchJune 31,30, 2025.
Results of Operation for the Six Months Ended June 30, 2026 and 2025
Sales and Cost of Sales
For the six months ended June 30, 2026, we had $20,210 of sales compared to $19,018 for the six months ended June 30, 2025. Our cost of sales for the six months ended June 30, 2026, was $11,113 compared to $12,105 for the six months ended June 30, 2025. The Company started to generate revenue in the beginning of 2020.
Professional fees
For the six months ended June 30, 2026, we incurred $17,603 of professional fee expenses compared to $23,165 for the six months ended June 30, 2025. The decrease in professional fees in the current period is attributed to a decrease in audit expenses.
General and administrative
For the six months ended June 30, 2026, we incurred $9,436 of general and administrative expense (“G&A”) compared to $15,874 for the six months ended June 30, 2025. The decrease in the current year is attributed to an decrease in lease expenses.
Other income (expense)
For the six months ended June 30, 2026, we had an interest expense of $1,249, compared to misc. income of $438 for the six months ended June 30, 2025.
We have an accumulated deficit of $987,832$1,000,168 and
had a net loss of $7,830$12,337 for the threesix months ended MarchJune 31,30, 2026.
We generatedused $4,570$1,598 from our operations for the six
three months ended MarchJune 31,30, 2026, compared to cash usedgenerated $8,387$23,111 for the threesix months ended MarchJune 31,30, 2025.
We generated $0 from investing activities for
the threesix months ended MarchJune 31,30, 2026, compared to generating $6,892 from investing activities for a right of use of asset in the prior
period.
We generated $0$2,000 for financing activities for
the the
threesix months ended MarchJune 31,30, 2026, compared to $438$2,062 usedgenerated for the threesix months ended MarchJune 31,30, 2025.
HIGR insider buying and selling (Form 4)
Since 2026-04-11, insiders reported open-market purchases in 0 Form 4 filings and open-market sales in 0 filings. Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.
No Form 4 stock transactions in this period.
Well-known investors holding HIGR (13F)
None of the 59 investors we track reported a position in their latest 13F.